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Christopher M. RileyI am delighted and honored to have been selected as the
first Editor-in-Chief of AAPS Open, an open-access
journal devoted to the rapid publication of quality
articles in the pharmaceutical sciences. The journal will
be a global forum for the barrier-free publication of
reports of original research, as well as other significant
work that demonstrates applications of scientific concepts
and techniques across the entire breadth of the field. Thus
AAPS Open will provide an important outlet for members
of AAPS sections and focus groups to publish papers of
interest to their communities, as well as for scientists
throughout the field.
All AAPS Open articles will be fully peer reviewed by
scientists with extensive knowledge in the subject matter.
The editorial team, consisting of the associate editors and
myself, has been aligned with the sections of AAPS to
ensure that all aspects of the pharmaceutical sciences are
covered, including but not limited to pharmaceutical and
biomedical analysis, quality control, quality assurance,
pharmaceutical biotechnology, biopharmaceutics, clinical
pharmacology, translational research, drug discovery
and its interface with drug development, formulation
design, manufacturing science and engineering, physical
pharmacy, pharmacokinetics, pharmacodynamics, drug
metabolism, and regulatory affairs.
I want to thank the following eight well-known
pharmaceutical scientists for agreeing to join the AAPS
Open editorial team as associate editors: Nagesh Bandi
(Pfizer), Varsha Bhatt-Mehta (University of Michigan),
Panos Constantinides (BioPharmaceutical & Drug Delivery
Consulting), Nikoletta Fotaki (University of Bath), Jayne
Hastedt (JPD Pharma), Tim Hickling (Pfizer), Jaime Marach
(CUSTOpharm) and Jean Lee (BioQualQuan). We are in
the process of assembling a noteworthy editorial board
comprised of internationally recognized pharmaceut-
ical scientists who will help guide the journal.Correspondence: criley@rileyandrabel.com
Riley and Rabel Consulting Services, Maryville, MO, USA
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license, and indicate if changes were made.One of the obvious advantages of publishing in a
completely open-access journal is the speed of publication.
Given the ever-increasing pace of drug development, we
hope that this advantage will encourage the publication of
critical issues in drug development and stimulate lively
discussions. AAPS Open will provide an opportunity for
pharmaceutical scientists to share their experiences during
the normal course of drug development as well as original
research articles, reviews, opinions, commentaries, and
industry best practices. We also encourage the submission
of protocols of general interest and databases. The journal
is open for submissions now. Membership in AAPS is not
a requirement for publication in AAPS Open, and we look
forward to receiving articles for consideration that will be
of interest to everyone involved in the drug research and
development.
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